BioNTech (BNTX) returns
BioNTech returns over 5 years
$1,000 invested in BioNTech five years ago was worth $323.59 at the close on October 30, 2026, with dividends reinvested: an average return of -20.2% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -10.3% | — | $896.95 | -0.9% |
| 3 months | -5.0% | — | $949.60 | +2.1% |
| Year to date | -7.4% | — | $926.16 | +11.7% |
| 1 year | -15.8% | — | $842.36 | +12.4% |
| 3 years | -5.4% | -1.8% | $945.52 | +88.5% |
| 5 years | -67.6% | -20.2% | $323.59 | +76.0% |
BioNTech return by calendar year
| Year | BNTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -7.4% | +11.7% | -19.1% |
| 2025 | -16.5% | +17.7% | -34.2% |
| 2024 | +8.0% | +24.9% | -16.9% |
| 2023 | -29.7% | +26.2% | -55.9% |
| 2022 | -40.4% | -18.2% | -22.2% |
| 2021 | +216.2% | +28.7% | +187.5% |
| 2020 | +140.6% | +18.4% | +122.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: BNTX financials · BNTX valuation
No forecast, no recommendation. This page describes BioNTech from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.